Applications published 21 November 2007

Nitric oxide enhancing diuretic compounds, compsns and methods of use
Nitromed 1855688*

Pharmaceutical compsns comprising anticholinergics and etiprednol
Boehringer Ingelheim International 1855689*

A tetracycline metal complex in a solid dosage form
Warner Chilcott 1855690*

The use of thiophesphonoformic acid and NRTIS to treat viral infections
Adventrix Pharmaceuticals 1855691*

• Compsn for reducing the exudation of serum proteins
Choi, Seong-hyun 1855692*

• Azithromycin powder for oral suspension compsns
Teva Pharmaceutical Industries 1855693*

• Antisense compsn and method for treating muscle atrophy
AVI BioPharma 1855694*

• Solid pharmaceutical compsn comprising telithromycin
Aventis Pharma 1855695*

• 9A-carbamoyl-y-aminopropyl- and 9A-thiocarbamoyl-y-aminopropyl-azalides with antimalarial activity
Glaxo SmithKline istrazivacki centar Zagreb 1855696*

• Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumours
Gentium 1855697*

• Light pharmaceutical water and therapeutic compsns and methods thereof
VADA Consulting 1855699*

• Use of neuronal precursor cells for treatment of central nervous system lesions
SanBio 1855700*

• Metal chelator
Georgiou, George 1855701*

• Herbal compsns for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same
Shenzen Qianrenren Sci & Tech Development Co 1855702*

• Formulations and methods for delivery of growth factor analogues
Biosurface Engineering Technologies 1855703*

• Facially amphiphilic polymers and oligomers, compsns thereof, and use thereof in methods of treating cancer
The Trustees of the University of Pennsylvania; University of Massachusetts 1855704*

• Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compsns, and use thereof
Vicuron Pharmaceuticals 1855705*

• Single branch heparin-binding growth factor analogues
Biosurface Engineering Technologies 1855706*

• Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
Oncotherapy Science 1855707*

• Treating anaemia by inhibition of VEGF
Regeneron Pharmaceuticals 1855708*

• Use of myostatin (GDF08) antagonists for improving wound healing and preventing fibrotic disease
Orico 1855709*

• Muscle regeneration
Orico 1855710*

• Use of BAFF to treat Th2-mediated conditions
Biogen Idec; The Garvan Institute of Medical Research 1855711*

• FXIII variants with improved properties
Novo Nodisk Health Care 1855712*

• Genetically engineered equine influenza virus and uses thereof
Mount Sinai School of Medicine of the City University of New York; The University of Kentucky Research Foundation 1855713*

• Methods of reducing the symptoms of autoimmunity and inflammation using binding proteins against antigens exposed on dead or dying cells
The Regents of the University of California 1855714*

• GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
Children's Hospital & Research Centre at Oakland 1855715*

• Compsns for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
Cornell Research Foundation 1855716*

• Surface located streptococcus pneumoniae polypeptides
Ace Biosciences 1855717*

• Adhesin as immunogen against escherichia coli
The United States of America as represented by the Secretary of the Navy 1855718*

• Neutralising monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
The New York Blood Centre 1855719*

• Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
Bavarian Nordic 1855720*

Method and compsn for treating mammalian diseases and injuries caused by the over-expression of peroxynitrile
North Cell Pharmaceuticals 1855721*

• Compounds for stabilising factor VII polypeptide formulations
Novo Nordisk 1855722*

• Targeted drug-carrying bacteriophages
Ramot at Tel Aviv University 1855723*

• Blys fusion proteins for targeting Blys receptor and methods for treatment of B-cell proliferative disorders
Research Development Foundation 1855724*

• Cyclodextrin-based polymers containing photocleavable linkers for drug delivery
Insert Therapeutics 1855725*

• Compsns and methods for the therapeutic treatment of diabetes
Biotech Institute for International Innovation 1855726*

• Compsns, kits and methods for identification, assessment, prevention and therapy of cancer
Dana-Farber Cancer Institute 1855727*

• An apparatus and method of ultrasonic cleaning and disinfection
Cavitus 1855728*